BRYAN DOOLEY: Open Payments
NPI 1346707379 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 25 payments from 10 companies in 2025. Trend: 2023 $209 · 2024 $85 · 2025 $764
Food & beverage: $684Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $185 |
| ABBVIE INC. | 5 | $157 |
| Janssen Scientific Affairs, LLC | 1 | $84 |
| GENZYME CORPORATION | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| LEO Pharma Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Amgen Inc. | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $28 |
| Biofrontera Inc. | 1 | $24 |
Products named: TREMFYA, RINVOQ, DUPIXENT, ANZUPGO, COSENTYX, OTEZLA, NEMLUVIO, AMELUZ.
Industry payments across OH — which companies pay providers there.
